270 related articles for article (PubMed ID: 25355818)
1. Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.
Gómez-Moutón C; Fischer T; Peregil RM; Jiménez-Baranda S; Stossel TP; Nakamura F; Mañes S
Blood; 2015 Feb; 125(7):1116-25. PubMed ID: 25355818
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.
Lagane B; Chow KY; Balabanian K; Levoye A; Harriague J; Planchenault T; Baleux F; Gunera-Saad N; Arenzana-Seisdedos F; Bachelerie F
Blood; 2008 Jul; 112(1):34-44. PubMed ID: 18436740
[TBL] [Abstract][Full Text] [Related]
3. WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.
Liu Q; Chen H; Ojode T; Gao X; Anaya-O'Brien S; Turner NA; Ulrick J; DeCastro R; Kelly C; Cardones AR; Gold SH; Hwang EI; Wechsler DS; Malech HL; Murphy PM; McDermott DH
Blood; 2012 Jul; 120(1):181-9. PubMed ID: 22596258
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4.
Luo J; De Pascali F; Richmond GW; Khojah AM; Benovic JL
J Biol Chem; 2022 Feb; 298(2):101551. PubMed ID: 34973340
[TBL] [Abstract][Full Text] [Related]
5. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
[TBL] [Abstract][Full Text] [Related]
6. Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus.
Mueller W; Schütz D; Nagel F; Schulz S; Stumm R
PLoS One; 2013; 8(5):e64975. PubMed ID: 23734232
[TBL] [Abstract][Full Text] [Related]
7. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
Bachelerie F
Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
[TBL] [Abstract][Full Text] [Related]
8. The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4.
Wang L; Xiong Q; Li P; Chen G; Tariq N; Wu C
BMC Mol Cell Biol; 2021 Jan; 22(1):8. PubMed ID: 33485325
[TBL] [Abstract][Full Text] [Related]
9. Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor.
McCormick PJ; Segarra M; Gasperini P; Gulino AV; Tosato G
PLoS One; 2009 Dec; 4(12):e8102. PubMed ID: 19956569
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4
Zmajkovicova K; Pawar S; Maier-Munsa S; Maierhofer B; Wiest I; Skerlj R; Taveras AG; Badarau A
Genes Immun; 2022 Sep; 23(6):196-204. PubMed ID: 36089616
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.
Balabanian K; Levoye A; Klemm L; Lagane B; Hermine O; Harriague J; Baleux F; Arenzana-Seisdedos F; Bachelerie F
J Clin Invest; 2008 Mar; 118(3):1074-84. PubMed ID: 18274673
[TBL] [Abstract][Full Text] [Related]
12. Enhanced function with decreased internalization of carboxy-terminus truncated CXCR4 responsible for WHIM syndrome.
Kawai T; Choi U; Whiting-Theobald NL; Linton GF; Brenner S; Sechler JM; Murphy PM; Malech HL
Exp Hematol; 2005 Apr; 33(4):460-8. PubMed ID: 15781337
[TBL] [Abstract][Full Text] [Related]
13. AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome.
McDermott DH; Lopez J; Deng F; Liu Q; Ojode T; Chen H; Ulrick J; Kwatemaa N; Kelly C; Anaya-O'Brien S; Garofalo M; Marquesen M; Hilligoss D; DeCastro R; Malech HL; Murphy PM
J Cell Mol Med; 2011 Oct; 15(10):2071-81. PubMed ID: 21070597
[TBL] [Abstract][Full Text] [Related]
14. WHIM Syndrome Caused by Waldenström's Macroglobulinemia-Associated Mutation CXCR4 (L329fs).
Liu Q; Pan C; Lopez L; Gao J; Velez D; Anaya-O'Brien S; Ulrick J; Littel P; Corns JS; Ellenburg DT; Malech HL; Murphy PM; McDermott DH
J Clin Immunol; 2016 May; 36(4):397-405. PubMed ID: 27059040
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.
Dotta L; Tassone L; Badolato R
Curr Mol Med; 2011 Jun; 11(4):317-25. PubMed ID: 21506920
[TBL] [Abstract][Full Text] [Related]
16. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
[TBL] [Abstract][Full Text] [Related]
17. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.
Kawai T; Choi U; Cardwell L; DeRavin SS; Naumann N; Whiting-Theobald NL; Linton GF; Moon J; Murphy PM; Malech HL
Blood; 2007 Jan; 109(1):78-84. PubMed ID: 16946301
[TBL] [Abstract][Full Text] [Related]
18. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
Balabanian K; Lagane B; Pablos JL; Laurent L; Planchenault T; Verola O; Lebbe C; Kerob D; Dupuy A; Hermine O; Nicolas JF; Latger-Cannard V; Bensoussan D; Bordigoni P; Baleux F; Le Deist F; Virelizier JL; Arenzana-Seisdedos F; Bachelerie F
Blood; 2005 Mar; 105(6):2449-57. PubMed ID: 15536153
[TBL] [Abstract][Full Text] [Related]
19. Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.
Galli J; Pinelli L; Micheletti S; Palumbo G; Notarangelo LD; Lougaris V; Dotta L; Fazzi E; Badolato R
Orphanet J Rare Dis; 2019 Feb; 14(1):61. PubMed ID: 30819232
[TBL] [Abstract][Full Text] [Related]
20. The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.
McDermott DH; Liu Q; Ulrick J; Kwatemaa N; Anaya-O'Brien S; Penzak SR; Filho JO; Priel DA; Kelly C; Garofalo M; Littel P; Marquesen MM; Hilligoss D; Decastro R; Fleisher TA; Kuhns DB; Malech HL; Murphy PM
Blood; 2011 Nov; 118(18):4957-62. PubMed ID: 21890643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]